Statins, Muscle Health, and Ageing: What the Evidence Really Shows

There is a lot of noise on social media about statins and muscle health.

Many of the questions I receive in clinic reflect this, including what are statins, what are statins used for, and are statins bad for you.

This article reflects how I usually explain the evidence to patients. While decisions about statins should always be personalised, the principles below apply to most people. It is also a reminder that persuasive online narratives do not always reflect the full picture. When it comes to long-term cardiovascular health, evidence matters.

‍

Why this question matters

Muscle mass and strength play a crucial role in healthy ageing. They help us to:

• Stay mobile
• Remain independent
• Reduce the risk of frailty and falls
• Maintain strength and resilience as we age

Because statins are often prescribed for decades, it is reasonable to ask whether they affect muscle health over time, and what can be done to minimise any potential risk.

‍

What are statins and what are they used for?

Statins are medications used to lower LDL cholesterol and other harmful blood lipids. Lowering LDL cholesterol is one of the most effective ways to reduce the risk of atherosclerotic cardiovascular disease (ASCVD), including heart attacks and strokes.

Statins are the most commonly prescribed lipid-lowering drugs worldwide. In the UK, NICE guidelines recommend statins as first-line treatment because they are effective, well studied, and cost-effective for people at increased cardiovascular risk.

In simple terms, statins are used to reduce cardiovascular risk and prevent serious events, particularly in people with raised cholesterol or existing risk factors.

‍

Are statins bad for you? Understanding the pros and cons

When people ask whether statins are “bad”, they are usually weighing up the pros and cons of statins.

For most people at risk of cardiovascular disease:

• The benefits of statins are clear and well established
• Serious side effects are uncommon
• Long-term outcome data are stronger than for most alternative drugs

However, statins are not the only option.

‍

Alternatives to statins

For people who cannot tolerate statins, or who need additional LDL reduction, NICE guidance allows for alternatives such as:

• Ezetimibe
• PCSK9 inhibitors
• Other agents, including bempedoic acid or inclisiran, in specific cases

These medications are used less frequently because they are more expensive, often prescribed in specialist settings, and have less long-term outcome data than statins.

For most people, statins remain the foundation of lipid lowering, with alternatives available when needed.

‍

Why do studies on statins and muscle health seem to disagree?

You may hear that “studies disagree” about statins and muscle health. In reality, this usually reflects different types of studies answering different questions.

‍

What randomised controlled trials show

Randomised controlled trials (RCTs) compare people taking a statin with those taking a placebo.

These studies show that:

• Mild muscle aches can occur early on
• Serious muscle injury is rare
• There is no significant loss of muscle strength or function over months to a few years

However, RCTs are usually short-term and involve relatively healthy participants. This means they may not detect very subtle changes that occur over decades.

‍

What real-world (observational) studies show

Observational studies follow large groups of people over many years in everyday life.

These studies suggest that:

• Small, gradual declines in muscle mass or grip strength can occur in some statin users
• These changes are subtle and more noticeable with ageing

Importantly, observational studies cannot prove that statins are the direct cause. People taking statins are often older or less active to begin with.

‍

Putting the evidence together

When we combine both types of evidence:

• RCTs show that statins do not cause sudden or severe muscle damage
• Observational studies suggest that small, gradual changes may occur over many years

Overall, the evidence indicates that statins are safe in the short term, and that long-term muscle health is shaped far more by activity, nutrition, and metabolic health than by statin use alone.

‍

Why muscle symptoms are more common in real life: the nocebo effect

In clinical trials, most people tolerate statins well. Yet muscle symptoms are reported more frequently outside of trials.

This is largely explained by the nocebo effect, when symptoms occur because of expectation or concern, rather than direct muscle damage.

‍

The SAMSON trial in plain language

The SAMSON trial studied people who had stopped statins due to muscle symptoms. Participants took a statin, a placebo, or no tablets at different times and recorded their symptoms.

Symptoms were:

• Low with no tablets
• Almost identical with placebo and statin

This showed that most muscle symptoms attributed to statins also occurred when people took an inactive pill. After seeing the results, around half of participants were able to restart statins.

Muscle symptoms are real, but in many cases they are not caused by the statin itself.

‍

What really protects muscle health with ageing

Some long-term studies show small declines in muscle mass or strength in statin users. These changes are subtle and cannot be confidently attributed to statins alone.

The strongest predictors of muscle health over time are:

• Physical activity
• Adequate nutrition
• Metabolic health

‍

Exercise: the most important protective factor

Exercise is the single most effective way to protect muscle health, whether or not you take statins.

• Resistance training helps build and preserve muscle
• Aerobic exercise supports endurance and mitochondrial function

People who remain physically active while taking statins consistently report fewer muscle complaints and better physical function.

‍

Protein, fibre, and digestion

As we age, muscles become less responsive to protein, a process known as anabolic resistance.

General guidance includes:

• 1.2–1.6 g protein per kg body weight per day
• 30–40 g protein per meal
• A mix of animal and plant protein sources

Fibre-rich plant foods also support gut health, reduce inflammation, and indirectly support muscle and metabolic health.

Age-related digestive changes and long-term PPI use can impair protein absorption, making digestion an important but often overlooked factor.

‍

Supplements: a personalised approach

‍

Coenzyme Q10

Statins can reduce CoQ10 production, but not everyone becomes deficient or symptomatic. Some people notice benefit from supplementation, while others do not. Testing and personalisation help guide decisions.

‍

Creatine

Creatine is one of the most well-studied supplements for strength and lean mass. It is safe in older adults and particularly effective when combined with resistance training.

‍

Statins, mitochondria, and common myths

Claims that statins are “mitochondrial poisons” are misleading. While statins slightly reduce CoQ10, real-world doses do not meaningfully impair strength or endurance in most people.

Tracking fitness markers such as VO₂ max over time can be a practical way to monitor mitochondrial health. The fitter you get the better the mitochondrial are. In simple terms even with taking a high intensity statin dose getting fit outways any potential issues.

‍

Putting statins into context

Social media scare stories can discourage people from taking medications that reduce cardiovascular risk and save lives.

When used appropriately, statins work best as part of a broader strategy that includes:

• Regular exercise
• Adequate protein and fibre
• Ongoing, personalised monitoring

‍

The bottom line

• Statins reduce cardiovascular risk and save lives
• They do not cause rapid muscle loss
• Small, gradual changes may occur over decades
• Lifestyle factors are the dominant drivers of muscle ageing

‍

For most people, statins support cardiovascular health without compromising muscle health, especially when combined with an active lifestyle and good nutrition.

‍